Seeking evidence that cell kill guided thermotherapy gives results not inferior to those of transurethral prostate resection: results of a pooled analysis of 3 studies of feedback transurethral microwave thermotherapy.

PURPOSE We compared ProstaLund Feedback Treatment (PLFT) to transurethral prostate resection (TURP) in terms of efficacy and safety in a pooled analysis of 3 clinical studies with 1-year followup. MATERIALS AND METHODS Overall raw data on 183 patients with PLFT and 65 with TURP were pooled. All studies had identical inclusion criteria, and the efficacy and safety of the method were evaluated using the International Prostate Symptom Score, maximum urine flow (Qmax), responder rate, bother score, prostate volume reduction and adverse events. RESULTS The response rate was 85.3% and 85.9% in the PLFT and TURP groups, respectively. One-sided 95% CI analysis showed the noninferiority of PLFT vs TURP for this variable. Mean International Prostate Symptom Score was significantly decreased in the PLFT and TURP groups after 12 months (from 20.9 to 6.4 and 20.7 to 7.1, respectively). The 1-sided upper 95% CI of PLFT was within the noninferiority definition compared with that of TURP. The bother score decrease in the PLFT and TURP groups was not significant different (70.9% and 64.0%, respectively). An increase in Qmax from 7.7 to 16.1 ml per second 12 months after PLFT was noted, while the improvement in Qmax in the TURP group was higher (from 7.5 to 18.6 ml per second). The 1-sided lower 95% CI was close (0.76) but it did not attain the predetermined level of noninferiority (0.80). Mean transurethral ultrasound determined volume 12 months after PLFT and TURP was reduced by 32.8% and 58.1%, respectively. A significant correlation between the transurethral ultrasound determined prostate volume reduction and estimated cell kill was found (r = 0.456, p <0.000001). Serious adverse events with causality occurred in 15.4% of patients with TURP compared with 6.0% in those with PLFT (p = 0.035). CONCLUSIONS Combined experience from our pooled analysis indicates that PLFT challenges TURP in terms of efficacy and safety after 1 year of followup.

[1]  J. J. de la Rosette,et al.  Efficacy and safety of intraprostatic temperature-controlled microwave thermotherapy in patients with benign prostatic hyperplasia: results of a prospective, open-label, single-center study with 1-year follow-up. , 2003, Journal of endourology.

[2]  J. J. de la Rosette,et al.  Transurethral microwave thermotherapy: the gold standard for minimally invasive therapies for patients with benign prostatic hyperplasia? , 2003, Journal of endourology.

[3]  A. Mattiasson,et al.  Feedback microwave thermotherapy versus TURP for clinical BPH--a randomized controlled multicenter study. , 2002, Urology.

[4]  L. Kiemeney,et al.  Long-term followup of randomized transurethral microwave thermotherapy versus transurethral prostatic resection study. , 2001, The Journal of urology.

[5]  S. Schelin.  Microwave Thermotherapy in Patients with Benign Prostatic Hyperplasia and Chronic Urinary Retention , 2001, European Urology.

[6]  J. J. de la Rosette,et al.  Cell-kill modeling of microwave thermotherapy for treatment of benign prostatic hyperplasia. , 2000, Journal of endourology.

[7]  J. J. de la Rosette,et al.  Intraprostatic temperature monitoring during transurethral microwave thermotherapy: status and future developments. , 2000, Journal of endourology.

[8]  A. Tubaro,et al.  Relation between intraprostatic temperature and clinical outcome in microwave thermotherapy. , 2000, Journal of endourology.

[9]  L. Kiemeney,et al.  Clinical efficacy of a new 30‐min algorithm for transurethral microwave thermotherapy: initial results , 2000, BJU international.

[10]  A. Bitton,et al.  Transurethral thermotherapy for benign prostatic hyperplasia significantly decreases infravesical obstruction: results in 134 patients after 1 year. , 1999, The Journal of urology.

[11]  C. Roehrborn,et al.  Neoadjuvant and adjuvant alpha-blockade improves early results of high-energy transurethral microwave thermotherapy for lower urinary tract symptoms of benign prostatic hyperplasia: a randomized, prospective clinical trial. , 1999, Urology.

[12]  L. Brudin,et al.  Intraprostatic temperature monitoring during transurethral microwave thermotherapy for the treatment of benign prostatic hyperplasia. , 1998, The Journal of urology.

[13]  J. J. de la Rosette,et al.  Transurethral resection of the prostate vs high-energy thermotherapy of the prostate in patients with benign prostatic hyperplasia: long-term results. , 1998, British journal of urology.

[14]  J. Krogh,et al.  Transurethral microwave thermotherapy for treatment of benign prostatic hyperplasia: results obtained with the Prostalund device , 1998, World Journal of Urology.

[15]  G. Watson,et al.  Transurethral microwave thermotherapy (Prostatron version 2.5) compared with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: a randomized, controlled, parallel study. , 1997, British journal of urology.

[16]  J. J. de la Rosette,et al.  High-energy transurethral microwave thermotherapy: a thermoablative treatment for benign prostatic obstruction. , 1996, Urology.